Cephalon and takeover rival play their cards

The attempted $5.7 billion hostile takeover of Cephalon Inc., in Frazer, by Valeant Pharmaceuticals International Inc. moved to the dueling colored-card phase Thursday as each company told the Securities and Exchange Commission that it was sending stockholders notice of its hopes - and cards.